Urticaria in COVID-19. Case series presentation
Keywords:
COVID-19 / urticaria, COVID-19 / skin lesions, SARS-CoV-2.Abstract
Introduction: COVID-19 is currently considered a florid pathology of mandatory multidisciplinary management by medical specialties. For the dermatologist it represents a diagnostic challenge, due to the heterogeneity of clinical descriptions found at cutaneous level in these patients, so it is important to be attentive to this health emergency, given that although the virus is not dermatotropic, every day there is more evidence of cutaneous lesions produced by the new coronavirus.
Objective: to present a series of cases of patients with urticaria associated with COVID-19.
Case presentation: the 3 cases were female patients, young women between 19 and 27 years of age, with a history of allergies in 2 of them, who developed urticarial wheals almost simultaneously with the rest of the symptoms with positive PCR of nasopharyngeal exudate for SARS-CoV-2, with satisfactory clinical evolution and remission of the symptoms on the seventh day.
Conclusions: knowledge of the cutaneous manifestations allows to deepen in the still little-known aspects of COVID-19, to make a quicker diagnosis or even to serve as a prognostic marker. In the pandemic era, the diagnosis of infection should be considered in patients presenting with skin lesions, urticaria or angioedema with or without other symptoms and especially in those with atypical disease or with recent exposure to individuals infected by the virus.
Downloads
References
1. Pérez Abreu MR, Gómez Tejeda JJ, Dieguez Guach RA. Características clínico-epidemiológicas de la COVID-19. Rev haban cienc méd [Internet]. 2020 Abr [citado 22/10/2021]; 19(2):e3254. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2020000200005&lng=es
2. Machado Díaz M, Gómez Fonseca I, Rodríguez Pérez T, Bello Campo G, Canino Méndez N. Contribución de la pesquisa estudiantil al enfrentamiento al COVID-19 en un área de salud. Humanidades Médicas [Internet]. 2021 [citado 1/01/2021]; 21(1): 37-52. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-81202021000100037
3. OPS. Actualización Epidemiológica: Enfermedad por coronavirus (COVID-19) [Internet]. OPS; 22 de julio de 2021 [citado 1/01/2021]. Disponible en: https://www.paho.org/es/documentos/actualizacion-epidemiologica-enfermedad-por-coronavirus-covid-19-22-julio-2021
4. Sitio oficial del Ministerio de Salud Pública en Cuba [Internet]. La Habana [citado 22/10/2021]. Disponible en: https://salud.msp.gob.cu/parte-cierre-21-de-octubre-2021
5. López C, Cardona R. Urticaria asociada a COVID-19 en pacientes alérgicos. Rev Alerg Mex [Internet]. 2021 [citado 01/10/2021]; 68(3): 214-217 Disponible en: https://www.redalyc.org/articulo.oa?id=486771917010
6. Sánchez Linares V, Nieda Rosales L, Martínez Cuervo JJ. Manifestaciones cutáneas de Covid-19. Gac Méd Espirit [Internet]. 2020 Dic [citado 21/10/2021]; 22(3): 18-26. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1608-89212020000300018&lng=es
7. Amaya D, Sánchez A, Sánchez J. Urticaria inducible: serie de casos y revisión de la literatura. Biomédica [Internet]. 2016 [citado 01/10/2021]; 36(1): 10-21. Disponible en: https://revistabiomedica.org/index.php/biomedica/article/view/2678
8. García Acevedo CB, Guzmán Perera MG. Urticaria y angioedema asociados a COVID-19: presentación de cuatro casos. Acta Med [Internet]. 2021 [citado 02/10/2021]; 19(S1): 69-72. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=101031&id2=
9. González González F, Cortés Correa C, Peñaranda Contreras E. Manifestaciones cutáneas en pacientes con COVID-19: características clínicas y mecanismos fisiopatológicos postulados. Actas Dermosifiliogr [Internet]. 2021 [citado 1/08/2021]; 112(4): 314–323. Disponible en: https://www.actasdermo.org/es-manifestaciones-cutaneas-pacientes-con-covid-19-articulo-S0001731020305160
10. Cano Aguilar LE, Hernández Zepeda C, Vega Memije ME. Manifestaciones cutáneas primarias por el virus de síndrome respiratorio agudo coronavirus 2 (sars cov-2). Dermatología CMQ [Internet]. 2020 [citado 1/01/2021]; 18(2): 129-135. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=94208&id2=
11. Catalá A, Carretero Hernández G, Jiménez Rodríguez P, Fernández-Nieto D, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Academia española de dermatología y venereología. British Journal of dermatology [Internet]. 2020 abril [citado 02/08/2021]; 183(1): 71-77. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/bjd.19163
12. Cabezas-Olea R, Conde-Montero E, Company-Quiroga J, Alonso-García SR, et al. Manifestaciones cutáneas secuenciales de COVID-19. Dermatol Rev Mex [Internet]. 2021 [citado 1/08/2021]; 65(3): 450-458. Disponible en: https://dermatologiarevistamexicana.org.mx/article/manifestaciones-cutaneas-secuenciales-de-covid-19/
13. Arias-Argüello V. Manifestaciones cutáneas asociadas a COVID-19. Crónicas Científicas [Internet]. 2020 [citado 1/08/2021]; 16(16): 06-17. Disponible en: https://www.cronicascientificas.com/index.php/ediciones/edicion-xvi-setiembre-diciembre-2020/26-ediciones/274-manifestaciones-cutaneas-asociadas-a-covid-19
14. Castro Caicedo KY, Castro Caicedo GA, Giler Navia DX, Gaybor Chancay KM. Lesiones dermatológicas en COVID-19. RECIAMUC [Internet]. 2020, nov [citado 11/07/2021]; 4(4): 238-247. Disponible en: https://reciamuc.com/index.php/RECIAMUC/article/view/560
15. Sánchez-Borges M, González-Díaz SN, Ortega-Martell JA, Rojo-Gutiérrez MI, Ansotegui-Zubeldia IJ. Manifestaciones cutáneas en los pacientes con COVID-19 con especial atención en la urticaria. Rev Alerg Mex [Internet]. 2021 Abril- Jun [citado 1/08/2021]; 68(2): 112-116. Disponible en: https://revistaalergia.mx./ojs/index.php/ram/article/view/841
16. Carrascosa JM, Morillas V, Bielsa I, Munera-Campos M. Manifestaciones cutáneas en el contexto de la infección por SARS-COV-2. Actas Dermosifiliogr [Internet]. 2020 Nov [citado 1/08/2021]; 111(9): 734–742. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458046/
17. Fernández Bosch A, Martínez de la Torre C, Córcoles García S, Serna Serrano B. Manifestaciones cutáneas por COVID-19 en paciente polisintomática. Rev Clin Med Fam [Internet]. 2020 [citado 22/10/20212021 ]; 13(3): 235-239. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-695X2020000300235&lng=es
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
